Polyplus-transfection(R) SA, the leading biotechnology company that supports gene and cell therapy by supplying innovative transfection solutions, today announces the availability of the first ...

BERKELEY, Calif.--(BUSINESS WIRE)--PolyPlus, a developer of high-energy lithium batteries, today announced it has been awarded $8.99 million by the U.S. Department of Energy (DOE) as part of its ...

March 31 (Reuters) - Sartorius (SATG.DE), opens new tab will acquire French lab technology company Polyplus for 2.4 billion euros ($2.62 billion) from private investors to strengthen its activities ...

Warburg Pincus has made an investment in Polyplus, a developer of technology used in gene and cell therapy. Warburg’s investment in Polyplus puts the latter at a valuation of more than 500 million ...

Polyplus’ LipidBrick is designed to expand the scope of lipid nanoparticle formulation usage in mRNA therapeutics and vaccine development. Polyplus, a French provider of solutions for advanced ...

Polyplus-transfection has announced that it is setting up a group called the "Polyplus in vivo Consortium". This group will be developed on a user group model and bring together research scientists ...

A California company called PolyPlus is working on new battery technology that is waterproof and can store 10 times the energy of today's lithium-ion batteries. Lithium metal-air batteries have been ...

Polyplus acquired e-Zyvec, which provides DNA design and production services for DNA vectors for gene therapy, biomanufacturing, and research. “When we launched e-Zyvec five years ago, the idea was to ...

Warburg Pincus agreed to sell Polyplus for €2.4 billion earlier than expected, with the company in high demand despite a challenging exit market – one that requires more “bespoke” approaches, managing ...

March 31 (Reuters) - Sartorius will acquire French lab technology company Polyplus for 2.4 billion euros ($2.62 billion) from private investors to strengthen its activities supplying cell and gene ...

March 31 (Reuters) - Sartorius SATG.DE said on Friday it would acquire France-based biotechnology company Polyplus for 2.4 billion euros ($2.62 billion) from private investors including Archimed and ...